BioSpace News Archive

Magellan Healthcare, the behavioral and specialty health subsidiary of Magellan Health, Inc., announced resources and programs to educate and support individuals in recognition of National Depression and Mental Health Awareness and Screening Month throughout October.

Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA).

The United States Department of Agriculture and the United States Food and Drug Administration signed a Memorandum of Understanding outlining strengthened coordination between the FDA and the USDA’s Agricultural Marketing Service and Foreign Agricultural Service to facilitate the export of milk and milk products from the United States.

Dr. Roberto Crea, Oliphenol LLC CEO, is pleased to announce the publication of a multi-centers study published in the “Antioxidants” journal, linking Oliphenol’s HIDROX® with the potential alleviating symptoms from Parkinson’s Disease.

Proteros Biostructures GmbH (Proteros) and X-Chem, Inc. (X-Chem) announced today the launch of an alliance with the goal of offering Hit-Identification and Target-to-Lead drug discovery services based on their complementary technology platforms.

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways for the treatment of cancer, autoimmune and inflammatory diseases, today announced the results for the three proposals considered and voted upon by its stockholders at its Special Meeting on October 1, 2020.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase an aggregate of 122,300 shares of Karyopharm’s common stock to 17 newly-hired employees, with a grant date of September 30, 2020.

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter of 2020 after the market close on Wednesday, October 28, 2020

Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, today announced a multi-year commitment to decreasing breast cancer screening disparities for Black women.